Crowley Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,810
Closed -$674K 41
2025
Q3
$674K Sell
4,810
-100
-2% -$13.5K 0.54% 34
2025
Q2
$617K Sell
4,910
-385
-7% -$48K 0.56% 33
2025
Q1
$725K Sell
5,295
-880
-14% -$126K 0.69% 30
2024
Q4
$944K Buy
+6,175
New +$1.04M 0.83% 26

Other funds holding BIIB

Crowley Wealth Management's BIIB Position: Q4 2025 in Review

Crowley Wealth Management sold out of Biogen (BIIB) in Q4 2025, closing a stake of 4,810 shares — an estimated $674K sold.

Crowley Wealth Management first reported a position in BIIB in Q4 2024 and held it in 4 quarters. The position peaked at $944K in Q4 2024. 997 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

  • Crowley Wealth Management reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
  • Crowley Wealth Management sold 4,810 Biogen shares in Q4 2025, an estimated $674K.
  • Crowley Wealth Management first reported a position in Biogen in Q4 2024 and held it in 4 quarters.
  • Crowley Wealth Management's Biogen position peaked at $944K in Q4 2024.
  • 997 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on Crowley Wealth Management's 13F filing for Q4 2025.